Somalogic, Incorporated

Somalogic Operating Co., Inc.

Stuart G Field

Malti P Nikrad

Stephen Alaric Williams

Rachel M Ostroff

Alex A E Stewart

Rosalynn Dianne Gill

Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

Methods, compositions, and kits for predicting whether a subject with chronic obstructive pulmonary disease (COPD) or at risk of developing COPD is likely to have progressive COPD are provided. Methods, compositions, and kits for predicting whether lung function is likely to decline in a subject with COPD or at risk for developing COPD are also provided.

Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof

Growing community of inventors

Fort Collins, CO, United States of America

Stuart G Field